Physician profile
Benjamin Bograd
NPI 1316174873
$420.17
in general payments reported to CMS, 2019-2025
16 companies · $52.76 in 2025
The $52.76 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $45.26 · 2021: $142 · 2022: $85.33 · 2023: $78.28 · 2024: $16.70 · 2025: $52.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $148.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $147.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $53.48 | 2021 | |
| Integra Lifesciences Corporation | $52.34 | 2021-2022 | |
| Hologic Sales and Service, LLC | $35.77 | 2023-2025 | Coolseal Generator, Sentimag |
| Davol INC. | $35.46 | 2021-2022 | |
| Abbvie INC. | $35.21 | 2023-2025 | Strattice Reconstructive Tissue Matrix Bps |
| Medtronic, INC. | $34.13 | 2023-2024 | Intellis Adaptivestim, Progrip |
| Baudax Bio INC. | $28.65 | 2021 | |
| Organogenesis INC. | $22.85 | 2023 | Puraply |
| Paratek Pharmaceuticals, INC. | $19.78 | 2025 | Nuzyra |
| Nabriva Therapeutics, Plc | $16.28 | 2022 | |
| Stimwave Technologies Incorporated | $16.28 | 2020 | |
| Venclose INC. | $15.43 | 2020 | |
| Acera Surgical, INC. | $14.64 | 2022 | |
| Innocoll Pharmaceuticals Limited | $14.50 | 2021 | |
| Focal Therapeutics, INC. | $13.55 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $11.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Bograd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.